Related Articles
RELB: A novel prognostic marker for glioblastoma as identified by population‑based analysis
High expression of GPNMB indicates an unfavorable prognosis in glioma: Combination of data from the GEO and CGGA databases and validation in tissue microarray
CDH2 expression is of prognostic significance in glioma and predicts the efficacy of temozolomide therapy in patients with glioblastοma
Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value
RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma